Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice-Reference-Cited by-同舟云学术

Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice

Published:2013-08-20 Issue:8 Volume:8 Page:e71601
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chapman Rosamund,Stutz Helen,Jacobs William,Shephard Enid,Williamson Anna-Lise

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;S Rerks-Ngarm;N Engl J Med,2009

2. Immune-correlates analysis of an HIV-1 vaccine efficacy trial;BF Haynes;N Engl J Med,2012

3. Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses;ZM Ndhlovu;J Virol,2012

4. Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses;MJ Cayabyab;J Virol,2009

5. Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells;R Chapman;PLoS One,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine;npj Vaccines;2021-01-25

2. BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19;Immunobiology;2021-01

4. Mycobacterium bovis BCG in metastatic melanoma therapy;Applied Microbiology and Biotechnology;2019-08-12

5. Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model;PLOS Pathogens;2018-07-26